Lung CT Scans of COVID-19 Patients Can Predict Neurological Problems Revealed Later by Brain MRIs
For the first time, a multicenter study has found a visual correlation between the severity of the disease in the lungs using CT scans and the severity of effects on patient’s brains, using MRI scans. More...15 Mar 2021
Bioperfectus SARS-CoV-2 Antigen Rapid Test Kit with High Sensitivity and Specificity Assists in Fight against COVID-19 Pandemic
Jiangsu Bioperfectus Technologies Co., Ltd.’s (Shanghai, China) Novel Corona Virus (SARS-CoV-2) Antigen Rapid Test Kit with clinically proven high sensitivity and specificity is playing an important role in COVID-19 diagnostics as a fast and cost-efficient antigen test. More...12 Mar 2021
New Assay Detects Brazilian and South African SARS-CoV-2 Variants Faster than Sequencing, Screens More Samples
SeqOnce Biosciences (Pasadena, CA, USA) has launched its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 E484K variant at a faster rate than sequencing with the ability to screen more samples. More...12 Mar 2021
First-Ever T Cell-Based Test to Detect Prior SARS-CoV-2 Infection Receives FDA Emergency Use Authorization
The first and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2 has been granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA). More...12 Mar 2021
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Ultrasonic Cleaner
Cole-Parmer Ultrasonic Cleaner with Digital Timer
New
Vertebral Body Replacement System
Hydrolift
In Other News
Thermo Fisher’s New Customizable TaqMan SARS-CoV-2 Mutation Panel Allows Labs to Choose Which Variants to Track
Antibody-Based COVID-19 Drugs that Neutralize Original Coronavirus May Not Be Effective Against New SARS-CoV-2 Variants
New Fast and Easy-to-Perform COVID-19 Test Detects New Emerging SARS-CoV-2 Variants in Just Over One Hour
PerkinElmer Launches Comprehensive Solutions for Detecting SARS-CoV-2 Mutations
First of Its Kind Product Receives CE-Marking for Respiratory Infection Detection Using Smart Wearable Technology
New Predictive Model Helps Identify Those at Risk for Severe COVID-19
Endotracheal UVA Light Treatment Significantly Reduces SARS-CoV-2 Viral Load in Critically Ill COVID-19 Patients
Pioneering COVID-19 Testing Platform Combines Saliva-Based Sampling, Pooled Testing and PCR Diagnostics
First-Ever COVID-19 Test Measures Neutralizing Antibodies that Prevent SARS-CoV-2 from Entering Host Cells
New Quantitative Strategy for Pooling COVID-19 Tests Could Detect Outbreaks Early
CRISPR-Based mRNA Treatment Delivered to Lungs via Nebulizer Stops Replication of SARS-CoV-2 Virus
Merck’s Oral COVID-19 Antiviral Treatment Causes Quick Reduction in SARS-CoV-2
New COVID-19 Test Detects Cell Mediated (T Cell) Immune Response to SARS-CoV-2 Infection
Low-Cost and Fast COVID-19 Test Detects SARS-CoV-2 from Pool of Gargle Lavage Samples in One Hour
Unique Low-Cost, Non-Electric Ventilator Could Help Hospitals Treat COVID-19 Patients
Breakthrough Therapy Designated Oral Drug Could Protect or Reverse COVID-19-Induced Heart Damage
Administering Zinc Aids Recovery and Reduces Mortality in COVID-19 Patients, Finds New Study
Rapid Molecular Diagnostic Platform Sends Precise COVID-19 RNA Results to Smartphone in Minutes
Seegene's Latest COVID-19 Test Simultaneously Targets Four SARS-CoV-2 Genes and Recognizes Multiple Virus Variants
Certain Blood Types Could Be Associated with Greater Risk of Contracting COVID-19, Confirms New Study
Robotic Next Generation Sequencing Platform Accurately Screens Thousands of COVID-19 Samples at Once
Seegene Submits Allplex SARS-CoV-2/FluA/FluB/RSV Assay for US FDA Emergency Use Authorization
YHLO Launches New SARS-CoV-2 Neutralization Antibody (NAb) Assay
